HTHideki Takahashi

Hideki Takahashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hideki Takahashi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients

    by Hideaki Mochizuki, Yuta Nanjo, Hideki Takahashi

    Background:  Inhaled long‐acting β2‐agonists (LABA) are often poorly adhered to by elderly patients with chronic obstructive pulmonary disease (COPD). We hypothesized that older age and compromised cognitive function might contribute to poor adherence to inhaled medications among COPD patients, and that transdermally delivered medications could improve adherence, exercise tolerance and quality of life (QOL).Objective:  To compare adherence and effects on health outcomes between transdermal and inhaled LABA.Methods:  A total of 44 treatment‐naïve, elderly Japanese patients with moderate‐to‐severe COPD were treated with a transdermal tulobuterol patch (TP; 2 mg, once a day) or inhaled salmeterol (50 µg, twice a day) in a randomized crossover manner. The primary outcomes were adherence to the LABA medications and changes in QOL measured by the St George's Respiratory Questionnaire. Secondary outcomes were changes in 6‐min walk distance (6MWD) and spirometric values.Results:  The overall adherence rate was 90.3 ± 1.6% for TP and 75.5 ± 2.9% for salmeterol (P < 0.001). Adherence to salmeterol was correlated with age and Mini‐Mental State Examination (MMSE) score (P < 0.05 and P < 0.01, respectively), although that to TP was relatively constant regardless of age and MMSE score. 6MWD and QOL were significantly improved from baseline after TP, but not after salmeterol treatment (P < 0.05). Similar degrees of increase in spirometric values occurred after treatment with TP and salmeterol.Conclusions:  Adherence levels were higher overall with TP than with inhaled salmeterol, and more stable across age groups and MMSE levels. TP might be a favorable treatment option for COPD patients with poor adherence to an inhaled LABA. Geriatr Gerontol Int 2013; 13: 398–404.


  • β2-Adrenergic Receptor Haplotype may be Associated with Susceptibility to Desensitization to Long-Acting β2-Agonists in COPD Patients

    by Hideaki Mochizuki, Yuta Nanjo, Eriko Kawate, Mariko Yamazaki, Yasunari Tsuda, Hideki Takahashi

    Τhat β2-adrenergic receptor (β2AR) haplotypes may play a key role in clinical response to β2-agonists and haplotype Cys-19Gly16Gln27 (CysGlyGln) is reported to be associated with desensitization of β2AR to β-agonists in lymphocytes isolated from patients with asthma and septic shock. We sought to determine whether haplotypic variation of the β2AR affects the functional outcomes of long-acting β2-agonist (LABA) treatment for chronic obstructive pulmonary disease (COPD) when used as monotherapy. Treatment-naïve patients with COPD (n = 36) were prospectively treated with two kinds of LABA—inhaled salmeterol and transdermal tulobuterol patch—for 12 weeks in crossover study, and changes in pulmonary function data and 6-minute walk distance (6MWD) were compared between groups stratified by the CysGlyGln. Frequencies of haplotype and diplotype for the CysGlyGln were 0.51 and 0.36, respectively. The individuals homozygous for CysGlyGln showed less improvement in FEV1, %FEF25−75 %, and IC/TLC than those with 0 or 1 copy of CysGlyGln after treatment with both LABAs despite initial bronchodilator responses to albuterol being similar in these groups. The response in these parameters was not significantly different between two types of LABA. Overall changes in 6MWD in individuals with 2 copies of CysGlyGln versus 0 or 1 copy for salmeterol were 2.8 and 11 m, and for tulobuterol were −1.3 and 16 m, respectively. Homozygous haplotype for the CysGlyGln of β2AR may be associated with susceptibility to desensitization to LABA in patients with COPD.


  • Open Access

    A Retrospective Analysis of Clinical Outcomes of Patients Older Than or Equal to 80 Years with Small Cell Lung Cancer

    by Toshiyuki Noguchi, Hideaki Mochizuki, Mariko Yamazaki, Eriko Kawate, Yohei Suzuki, Teruhiko Sato, Hideki Takahashi


  • Two cases with solitary pulmonary nodule due to non‐tuberculous mycobacterial infection showing intense 18F‐fluorodeoxyglucose uptake on positron emission tomography scan

    by Eriko Kawate, Mariko Yamazaki, Tadashi Kohno, Sakashi Fujimori, Hideki Takahashi

    We report an 81‐year‐old man and a 65‐year‐old woman with a solitary pulmonary nodule (SPN) due to infection with non‐tuberculous mycobacteria (NTM). In each case, the nodule showed a high 18F‐fluorodeoxyglucose (FDG) uptake with the maximum standardized uptake values (SUV) of 13.2 and 4.8 on positron emission tomography (PET) imaging, respectively. Both cases required partial lung resection for confirmation of the histological diagnosis. A review of six reported patients with SPN due to NTM infections showed that the SUV of FDG was more than 4.0 in the nodules of all cases. Positive results on FDG‐PET should be interpreted cautiously when evaluating SPN, especially in patients having predisposing factors for NTM infections. Geriatr Gerontol Int 2010; 10: 251–254.


  • Patients with mild‐to‐moderate asthma may develop clinically significant chronic obstructive pulmonary disease

    by Yasunari Tsuda, Toshiyuki Noguchi, Hideaki Mochizuki, Fumihiko Makino, Yuta Nanjo, Motoji Sawabe, Hideki Takahashi

    Background and objective:  Little is known about the aetiology and clinical characteristics of COPD among people who have never smoked.Methods:  A case–control study was conducted to describe the potential risk factors for clinically significant COPD among smokers and people who had never smoked. Medical record reviews and scoring of high‐resolution computed tomography (HRCT) findings were performed in patients with clinically significant COPD (defined as having post‐bronchodilator FEV1/FVC < 0.7 and FEV1 < 60% of the predicted values). Pathological analyses were performed in some patients following autopsy.Results:  Among the 9493 subjects screened, 424 (4.5%) were diagnosed with clinically significant COPD. Forty‐nine (11.6% of clinically significant COPD) were never smokers (NSCOPD), and a comparative group of 98 smoking patients with COPD was randomly selected (SMCOPD). NSCOPD was characterized by predominantly female sex (87.8%) and a high prevalence of physician‐diagnosed asthma (61.2%). Similar levels of reduction in %FEV1 and %FEF25–75% were found in NSCOPD and SMCOPD, but there were higher %DLCO values and fewer low attenuation areas on HRCT in NSCOPD. More than half of the NSCOPD patients without a history of asthma had features of asthma. More than one‐third of NSCOPD patients with an asthma history had never had a severe attack. At autopsy, both NSCOPD and SMCOPD showed wall thickening and inflammatory cell infiltration in small airways, and the number of CD4+‐T cells was increased in NSCOPD.Conclusion:  In elderly Japanese, COPD among never smokers is largely attributable to asthma. Airflow limitation in NSCOPD results from small airway disease (airway predominant phenotype) rather than parenchymal destruction (emphysematous phenotype).


  • Undifferentiated carcinoma arising from ectopic thyroid tissue in the anterior mediastinum

    by Takashi Hasegawa, Yasunari Tsuda, Masako Sunakawa, Koji Uchida, Motoji Sawabe, Hideki Takahashi